FDA taps Wiley Chambers as interim Analgesic, Anti-Inflammatory Drugs Division head.
This article was originally published in The Tan Sheet
Executive Summary
FDA ANALGESIC, ANTI-INFLAMMATORY DRUGS DIVISION ACTING DIRECTOR CHAMBERS is taking on the temporary responsibilities of the position while FDA completes a search for a rheumatologist or analgesiologist to take on the permanent division director post. Wiley Chambers, MD, most recently served as a medical officer for ophthalmic drugs in the then-Division of Dermatologic & Ophthalmic Drugs.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning